Technetium-99m-MIBI-SPECT for prostate cancer diagnosis
The gold standard method for prostate cancer diagnosis is a transrectal ultrasonography-guided prostate biopsy. The detection rate of prostate cancer using the biopsy is approximately 25-30%. A non-invasive method Technetium-99m methoxy-isobutyl-isonitrile single-photon emission computed tomography...
Main Authors: | M. Kuru, Z. Talat, M. S. Sağer, Ç. Demirdağ |
---|---|
Format: | Article |
Language: | English |
Published: |
National Kidney Foundation of Ukraine
2020-01-01
|
Series: | Український Журнал Нефрології та Діалізу |
Subjects: | |
Online Access: | https://ukrjnd.com.ua/index.php/journal/article/view/388 |
Similar Items
-
Preparation and evaluation of modified composition for lyophilized kits of [Cu(MIBI)4]BF4 for [99mTc] technetium labeling
by: Marisa de Jesus de C. Lima, et al.
Published: (2005-10-01) -
Effect of 99mTc-MIBI SPECT/CT two-phase SPECT on diagnostic efficacy of hyperparathyroidism
by: LI Wenbo, et al.
Published: (2020-01-01) -
Diagnostic performance of ultrasonography, dual-phase 99mTc-MIBI scintigraphy, early and delayed 99mTc-MIBI SPECT/CT in preoperative parathyroid gland localization in secondary hyperparathyroidism
by: Rongqin Zhang, et al.
Published: (2020-08-01) -
The role of 99mTc-MIBI SPECT/CT in patients with secondary hyperparathyroidism: comparison with 99mTc-MIBI planar scintigraphy and ultrasonography
by: Shu-Qin Jiang, et al.
Published: (2020-10-01) -
SPECT-CT fusion in the diagnosis of hyperparathyroidism
by: Yoshio Monzen, et al.
Published: (2015-01-01)